“WHO”的搜索结果，显示 331-340 项，共有 15492 项
The second objective is to continue to identify whether there is a genetic link associated with MacTel Type 2. All participants who have not previously provided ...
... who are refractory to or intolerant to other available therapies. Also, to evaluate safety and tolerability and determine RP2D of YH001 in combination with ...
... who have no clinical evidence of residual (macroscopic) disease following an attempt to perform definitive treatment (including surgery, radiation and/or ...
... who are candidates for active surveillance and are undergoing voluntary radical prostatectomy (RP) [Cohort A] or routine prostate biopsy [Cohort B]. This ...
... who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have ...
These medicines only work in people who have certain DNA changes in their cancer cells. Your healthcare team may test your cancer cells to look for these ...
The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The ...
... who carries the gene change. In people without VHL disease, similar gene changes can happen later in life inside the tumor itself. These are called somatic ...
People who seek care at Mayo Clinic have access to the full range of treatments for CNS lymphoma. These may include chemotherapy, radiation therapy ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。